IXICO Overview
- Year Founded
-
1995
- Status
-
Public
- Employees
-
89
- Stock Symbol
-
IXI
- Investments
-
2
- Share Price
-
$0.15
- (As of Friday Closing)
IXICO General Information
Description
IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.
Contact Information
Website
www.ixico.comCorporate Office
- 4th Floor, Griffin Court
- 15 Long Lane
- London EC1A 9PN
- England, United Kingdom
Corporate Office
- 4th Floor, Griffin Court
- 15 Long Lane
- London EC1A 9PN
- England, United Kingdom
IXICO Stock Performance
As of 20-Jun-2025, IXICO’s stock price is $0.15. Its current market cap is $14.4M with 92.7M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.15 | $0.15 | $0.08 - $0.20 | $14.4M | 92.7M | 81.3K | -$0.03 |
IXICO Financials Summary
As of 31-Mar-2025, IXICO has a trailing 12-month revenue of $8.21M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 30-Sep-2024 | FY 2023 30-Sep-2023 | FY 2022 30-Sep-2022 |
|---|---|---|---|---|
| EV | 7,919 | 3,196 | 5,621 | 11,109 |
| Revenue | 8,208 | 7,308 | 8,163 | 11,033 |
| EBITDA | (1,343) | (2,128) | (995) | 1,975 |
| Net Income | (1,972) | (2,536) | (1,443) | 1,317 |
| Total Assets | 18,214 | 14,972 | 15,849 | 16,365 |
| Total Debt | 356 | 420 | 472 | 576 |
IXICO Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
IXICO Comparisons
Industry
Financing
Details
IXICO Competitors (2)
One of IXICO’s 2 competitors is Immunocore, a Formerly VC-backed company based in Abingdon, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immunocore | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Clarity Pharmaceuticals | Formerly VC-backed | Eveleigh, Australia |
IXICO Patents
IXICO Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201420436-D0 | Device | Inactive | 18-Nov-2014 | ||
| GB-0813666-D0 | Image data management systems | Inactive | 25-Jul-2008 | ||
| US-20100021027-A1 | Image data management systems | Inactive | 25-Jul-2008 | ||
| GB-0813672-D0 | Image data management systems | Inactive | 25-Jul-2008 | ||
| GB-0813668-D0 | Image data fraud detection systems | Inactive | 25-Jul-2008 | G16H30/40 |
IXICO Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
IXICO Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
IXICO Acquisitions (2)
IXICO’s most recent deal was a Merger/Acquisition with Optimal Medicine for . The deal was made on 01-Dec-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Optimal Medicine | 01-Dec-2015 | Merger/Acquisition | Decision/Risk Analysis | ||
| Phytopharm | 17-Oct-2013 | Merger/Acquisition | Pharmaceuticals |
IXICO FAQs
-
When was IXICO founded?
IXICO was founded in 1995.
-
Where is IXICO headquartered?
IXICO is headquartered in London, United Kingdom.
-
What is the size of IXICO?
IXICO has 89 total employees.
-
What industry is IXICO in?
IXICO’s primary industry is Biotechnology.
-
Is IXICO a private or public company?
IXICO is a Public company.
-
What is IXICO’s stock symbol?
The ticker symbol for IXICO is IXI.
-
What is the current stock price of IXICO?
As of 20-Jun-2025 the stock price of IXICO is $0.15.
-
What is the current market cap of IXICO?
The current market capitalization of IXICO is $14.4M.
-
What is IXICO’s current revenue?
The trailing twelve month revenue for IXICO is $8.21M.
-
Who are IXICO’s competitors?
Immunocore and Clarity Pharmaceuticals are competitors of IXICO.
-
What is IXICO’s annual earnings per share (EPS)?
IXICO’s EPS for 12 months was -$0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
